INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

Ionis Pharmaceuticals (IONS) CEO Monia sold 140 shares for $4,525 at $32.32 under a 10b5-1 plan

ByQuantisnow··Wall Street's wire, on your screen.

Insider transactions reported

Brett P Monia (Chief Executive Officer at Ionis Pharmaceuticals Inc., IONS) reported that they sold 140 shares for $4,525 at $32.32 on Mar 11, 2025. After these transactions the filing shows 180,980 shares held directly.

Reporting person
Monia Brett P
Role
Chief Executive Officer
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 11, 2025Open-market sale (S)Common Stock1-140$32.32$4,525180,980 direct

Holdings before and after

  • Common Stock: 181,120 to 180,980 direct

Footnotes from the filing

  1. 1. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

FAQ

What did Monia report in this IONS Form 4?

Brett P Monia (Chief Executive Officer at Ionis Pharmaceuticals Inc., IONS) reported that they sold 140 shares for $4,525 at $32.32 on Mar 11, 2025. After these transactions the filing shows 180,980 shares held directly.

How many IONS shares does Monia hold after this filing?

The filing shows 180,980 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this IONS insider sale made under a 10b5-1 plan?

The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Ask Ellis, your AI research assistant, about this story

Historical context for IONS

Earlier insider filings at IONS

Keep researching IONS

Our reporting on IONS

Quantisnow market dataNASDAQ
Ionis Pharmaceuticals Inc. logo
IONS
Ionis Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for IONS

Follow IONS and get a push notification the moment its next story breaks.

Full IONS profile on Quantisnow

Watch IONS for work, on its IR, comms or brand team or at an agency? Send every IONS item and its competitors' to your team's Slack or Teams.

Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.